Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    KiSS1 Suppresses Metastasis in Human Ovarian Cancer via Inhibition of Protein Kinase C Alpha

    Metastasis is a vital target for cancer treatment, since the majority of cancer patients die from metastatic, rather than the primary disease. KiSS1 has been identified as a metastasis suppressor gene in melanoma...

    Ying Jiang, Michael Berk, Lisam Shanjukumar Singh in Clinical & Experimental Metastasis (2005)

  2. Article

    Open Access

    Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma

    Thrombospondin1 (THBS1), cystene-rich protein 61 (Cyr61) and connective tissue growth factor (CTGF) are all involved in the transforming growth factor-beta (TGF-β) signal pathway, which plays an important role...

    Zhu-Qing Zhou, Wei-Hua Cao, Jian-Jun **e, **g Lin, Zhong-Ying Shen in BMC Cancer (2009)

  3. Article

    Open Access

    ICOS gene polymorphisms are associated with sporadic breast cancer: a case-control study

    Inducible costimulator (ICOS), a costimulatory molecular of the CD28 family, provides positive signal to enhance T cell proliferation. Its abnormal expression can disturb the immune response and entail an increa...

    Fengyan Xu, Dalin Li, Qiu** Zhang, Zhenkun Fu, Jie Zhang, Weiguang Yuan in BMC Cancer (2011)

  4. Article

    Open Access

    Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells

    Acute promyelocytic leukemia (APL) is characterized by the reciprocal translocation t(15;17), which fuses PML with retinoic acid receptor alpha (RARα). Although PML-RARα is crucially important for pathogenesis...

    Chengwu Zeng, Yan Xu, Ling Xu, **bao Yu, **g**g Cheng, Lijian Yang in BMC Cancer (2014)

  5. Article

    Open Access

    Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China

    Rituximab has been confirmed to improve the survival of patients with B cell indolent non-Hodgkin lymphomas (B-iNHLs) in Western world as previously reported, however, it is rarely reported in Chinese cohort. ...

    Zengjun Li, Fei Li, Shuhua Yi, Zhimin Gu, Zhen Yu, Yan Xu, **aoyan Feng in BMC Cancer (2015)

  6. Article

    Open Access

    Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients

    SLC52A3 was recently identified as a susceptibility gene for esophageal squamous cell carcinoma (ESCC). However, associations between the single nucleotide polymorphisms (SNPs) rs13042...

    Hua-Zhen Tan, Zhi-Yong Wu, Jian-Yi Wu, Lin Long, Ji-Wei Jiao, Yu-Hui Peng in BMC Cancer (2016)

  7. Article

    Open Access

    Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study

    To investigate the feasibility of strain elastography imaging in early detecting and predicting treatment response in patients receiving concurrent chemo-radiotherapy (CCRT) for locally advanced cervical cancer.

    Yan Xu, Li**g Zhu, Baorui Liu, Tong Ru, Huanhuan Wang, Jian He, Song Liu in BMC Cancer (2017)

  8. Article

    Open Access

    Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

    Programmed cell death ligand 1 (PD-L1) is a potential predictive biomarker of the response to anti-PD-L1/anti- programmed cell death 1 (PD-1) therapy in multiple cancers, including triple negative breast cance...

    Ming Li, Anqi Li, Shuling Zhou, Yan Xu, Yaoxing **ao, Rui Bi, Wentao Yang in BMC Cancer (2018)

  9. Article

    Open Access

    A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma

    Increasing evidence shows that dysregulated long non-coding RNAs (lncRNAs) can serve as potential biomarkers for cancer prognosis. However, lncRNA signatures, as potential prognostic biomarkers for esophageal ...

    Guo-Wei Huang, Yu-Jie Xue, Zhi-Yong Wu, **u-E Xu, Jian-Yi Wu, Hui-Hui Cao in BMC Cancer (2018)

  10. Article

    Open Access

    A novel approach to monitoring the efficacy of anti-tumor treatments in animal models: combining functional MRI and texture analysis

    The aim of this study was to evaluate the early anti-tumor efficiency of different therapeutic agents with a combination of multi-b-value DWI, DCE-MRI and texture analysis.

    Ming Meng, Huadan Xue, **g Lei, Qin Wang, **gjuan Liu, Yuan Li, Ting Sun in BMC Cancer (2018)

  11. Article

    Open Access

    Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study

    Laparoscopic surgery, fast-track perioperative treatment and XELOX chemotherapy are effective strategies for shortening the duration of hospital stay for cancer patients. This trial aimed to clarify the safety...

    Jun Li, **ang-**ng Kong, Jiao-Jiao Zhou, Yong-Mao Song, Xue-Feng Huang in BMC Cancer (2019)

  12. Article

    Open Access

    A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

    To reveal roles of reactive oxygen species (ROS) status in chemotherapy resistance and to develop a ROS scoring system for prognosis prediction in ovarian cancer.

    Chaoyang Sun, Ensong Guo, Bo Zhou, Wanying Shan, Jia Huang, Danhui Weng in BMC Cancer (2019)

  13. Article

    Open Access

    Characterizing MRI features of rectal cancers with different KRAS status

    To investigate whether MRI findings, including texture analysis, can differentiate KRAS mutation status in rectal cancer.

    Yanyan Xu, Qiaoyu Xu, Yanhui Ma, Jianghui Duan, Haibo Zhang, Tongxi Liu in BMC Cancer (2019)

  14. Article

    Open Access

    Correction to: A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

    Following publication of the original article [1], the authors reported an error in Fig. 1f.

    Chaoyang Sun, Ensong Guo, Bo Zhou, Wanying Shan, Jia Huang, Danhui Weng in BMC Cancer (2020)

  15. Article

    Open Access

    Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis

    A higher vitamin D intake improves the prognosis of early stage breast cancer (BC) patients. We hypothesized that vitamin D intake should refer to vitamin D receptor (VDR) expression. In order to prove this hy...

    Haiyan Xu, Zhenhua Liu, Hongtai Shi, Chunbin Wang in BMC Cancer (2020)

  16. Article

    Open Access

    Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils

    Selective activation of Delta-like 1 (DLL1)-Notch signaling is a new approach to activate CD8+ T cell and suppress tumor growth, while the efficacy remains modest. Lentinan (LNT) is a clinically used immunomodula...

    Haiyan Xu, Ziwei Qi, Qi Zhao, Jiao Xue, Jiaxing Zhu, Yan He, Guirong Liu in BMC Cancer (2022)

  17. Article

    Open Access

    Eczema as a protective factor for brain cancer: a meta-analysis

    Brain cancer is one of the most aggressive cancer types owing to poor treatment effects. Epidemiological studies have demonstrated that allergies may increase the disease risk. Therefore, this study evaluated ...

    Yun Zhu, Yirong Teng, Shuangyan Xu, Yinde Xu, Boheng Zhu, Weimin Yan, Jie Liu in BMC Cancer (2022)

  18. Article

    Open Access

    AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway

    Homo sapiens chromosome 2 clone RP11-339H12 (AC010883.5) is a dysregulated long non-coding RNA (lncRNA) that has never been investigated in cervical cancer (CC). Thus, the potential function and molecular mechani...

    Qiyu Gan, **a Huang, Wenrong Zhao, Hui Liu, Yan Xu, **aohua Zhang in BMC Cancer (2023)

  19. Article

    Open Access

    Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study

    About 10% of non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations are harbored as uncommon mutations. This study aimed to explore the efficacy and safety of dacomitin...

    **ngxiang Pu, Yu Zhou, Yi Kong, Bolin Chen, Aifang Yang, Jia Li, Kang Li in BMC Cancer (2023)

  20. Article

    Open Access

    Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma

    PANoptosis is a specific type of inflammatory programmed cell death (PCD) modality that can be involved in three key modes of cellular programmed cell death-pyroptosis, apoptosis and necroptosis. We analyzed P...

    Yan Xu, **gqi Hua, Hongliang Que, Tengyue Zeng, Quan Li, Junpeng Deng in BMC Cancer (2024)

previous disabled Page of 2